BankPlus Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$445K Sell
7,123
-135
-2% -$8.53K 0.19% 76
2026
Q2
$418K Buy
7,258
+225
+3% +$12.9K 0.19% 80
2026
Q1
$427K Sell
7,033
-3,118
-31% -$182K 0.22% 76
2025
Q4
$548K Sell
10,151
-328
-3% -$15.8K 0.3% 64
2025
Q3
$473K Buy
10,479
+555
+6% +$25.9K 0.28% 70
2025
Q2
$459K Buy
9,924
+466
+5% +$22.9K 0.3% 66
2025
Q1
$577K Buy
9,458
+247
+3% +$14.4K 0.42% 46
2024
Q4
$521K Buy
+9,211
New +$515K 0.39% 48

Other funds holding BMY

BankPlus Wealth Management's BMY Position: Q3 2026 in Review

BankPlus Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 1.9% in Q3 2026, selling an estimated $8.53K and leaving 7,123 shares worth $445K. The position accounts for 0.19% of the portfolio, ranked #76.

BankPlus Wealth Management first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $577K in Q1 2025. 2,541 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • BankPlus Wealth Management held 7,123 shares of Bristol-Myers Squibb worth $445K as of Q3 2026.
  • BankPlus Wealth Management sold 135 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.53K.
  • Bristol-Myers Squibb made up 0.19% of BankPlus Wealth Management's portfolio in Q3 2026, its #76 holding.
  • BankPlus Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • BankPlus Wealth Management's Bristol-Myers Squibb position peaked at $577K in Q1 2025.
  • 2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on BankPlus Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.